Comment on Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy. [Eur J Prev Cardiol. 2017
Abstract Background: Antiretroviral therapy improved the survival of patients with human immunodefic...
From a global perspective, cardiovascular disease (CVD) in human immunodeficiency virus (HIV) may re...
In the last 15 years, highly active antiretroviral therapy (HAART) has determined a dramatic reducti...
Comment on Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive ind...
Background We aimed to identify the prevalence of cardiovascular risk factors, and investigate preve...
As early and effective antiretroviral therapy has become more widespread, HIV has transitioned from ...
Background Cardiovascular disease (CVD) is expected to contribute a large noncommunicable disease bu...
Background: Cardiovascular disease (CVD) is expected to contribute a large non-communicable disease ...
With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-positive pati...
Cardiovascular disease is a class of diseases which involve the heart or blood vessels. Among Human ...
Introduction: Cardiovascular disease (CVD) is the leading cause of death in England and Wales. As pe...
Cardiovascular risk factors with HIV infection: a long and motley list Antiretroviral therapy: from ...
Background & Objectives: Cardiovascular diseases have been an emerging area of concern in the HIV po...
Comment on Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis invest...
Background With the aging of the population living with HIV, the absolute risk of cardiovascular dis...
Abstract Background: Antiretroviral therapy improved the survival of patients with human immunodefic...
From a global perspective, cardiovascular disease (CVD) in human immunodeficiency virus (HIV) may re...
In the last 15 years, highly active antiretroviral therapy (HAART) has determined a dramatic reducti...
Comment on Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive ind...
Background We aimed to identify the prevalence of cardiovascular risk factors, and investigate preve...
As early and effective antiretroviral therapy has become more widespread, HIV has transitioned from ...
Background Cardiovascular disease (CVD) is expected to contribute a large noncommunicable disease bu...
Background: Cardiovascular disease (CVD) is expected to contribute a large non-communicable disease ...
With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-positive pati...
Cardiovascular disease is a class of diseases which involve the heart or blood vessels. Among Human ...
Introduction: Cardiovascular disease (CVD) is the leading cause of death in England and Wales. As pe...
Cardiovascular risk factors with HIV infection: a long and motley list Antiretroviral therapy: from ...
Background & Objectives: Cardiovascular diseases have been an emerging area of concern in the HIV po...
Comment on Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis invest...
Background With the aging of the population living with HIV, the absolute risk of cardiovascular dis...
Abstract Background: Antiretroviral therapy improved the survival of patients with human immunodefic...
From a global perspective, cardiovascular disease (CVD) in human immunodeficiency virus (HIV) may re...
In the last 15 years, highly active antiretroviral therapy (HAART) has determined a dramatic reducti...
DOI